We therefore assessed whether the KCa3.1 agonist SKA-111 modulates cAMP-stimulated cystogenesis or cyst enlargement in Pkd1+/+ or Pkd1–/– metanephroi (Figure 2A). Here, PKD1 is linked to cyst.